Designs and characterizes nanomaterials—including engineered vesicles and lipid carriers—for controlled drug delivery. Emphasis on pulmonary and ocular routes, quantitative biocompatibility, and PBPK integration with biorelevant dissolution to predict in vivo performance and bioequivalence.